| Business Summary | | Unigene
Laboratories
Inc.
is
a
biopharmaceutical
company
engaged
in
the
research,
production
and
delivery
of
small
proteins
(peptides)
that
have
demonstrated
or
may
have
potential
medical
use.
The
Company
has
a
patented
manufacturing
technology
for
producing
many
peptides
cost-effectively.
The
Company
also
has
patented
technology
that
has
been
shown
to
deliver
orally
medically
useful
amounts
of
various
peptides
into
the
bloodstream.
The
Company's
primary
focus
has
been
on
the
development
of
Calcitonin
products
for
the
treatment
of
osteoporosis
and
other
indications.
The
Company
is
also
engaged
in
the
development
of
oral
and
nasal
Calcitonin
products. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Unigene
Laboratories
is
a
biotechnology
company
that
is
involved
in
the
research
and
production
of
laboratory
grade
Calcitonin,
and
the
production
and
marketing
of
bulk
pharmaceutical
grade
Calcitonin.
For
the
six
months
ended
6/30/01,
revenues
fell
74%
to
$362
thousand.
Net
loss
before
accounting
change
rose
14%
to
$6.4
million.
Results
reflect
the
achievement
in
developing
an
oral
Calcitonin
in
the
last
quarter,
partially
offset
by
the
absence
of
J.V.
cost. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Jay Levy, 77 Chairman
and Treasurer | -- | Warren Levy, Ph.D., 49 Pres,
CEO | $174K | Ronald Levy, Ph.D., 52 Exec.
VP, Sec., Director | 172K | James Gilligan, Ph.D., 49 VP-
Product Devel. | 156K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|